genomics

  • The genomics intelligence revolution Crunch Network

    The genomics intelligence revolution

    We’ve entered a new phase in the history of whole-genome sequencing; it has opened the door to understanding our entire world at the molecular level. With this intelligence, we’ll be able to understand, influence and optimize the way we interact with ourselves and our natural world. The promise of genomics is just beginning — we are at the leading edge of an intelligence… Read More

  • Bio
    Illumina wants to sequence your whole genome for $100

    Illumina wants to sequence your whole genome for $100

    The first sequencing of the whole human genome in 2003 cost roughly $2.7 billion, but DNA sequencing giant Illumina has now unveiled a new machine that the company says is “expected one day” to order up your whole genome for less than $100. Illumina’s CEO Francis deSouza showed off the machine, called the NovaSeq, onstage at the JP Morgan Healthcare Conference in downtown… Read More

  • Google Ventures-backed Clear Labs gets $13 million in Series B to nip food recalls in the bud

    Google Ventures-backed Clear Labs gets $13 million in Series B to nip food recalls in the bud

    Clear Labs, a genomic data platform hoping to stop E-coli outbreaks in your favorite burrito chain before they start, has pulled in $13 million in Series B funding to build a next-generation sequencing-based (NGS) microbiome test and grow the business. It’s often hard for food manufacturers to know the origins of an infected batch before it goes out to the public. However, Clear Labs… Read More

  • Bio
    Genetics startup Genos wants to pay you for your DNA data

    Genetics startup Genos wants to pay you for your DNA data

    The first whole human genome sequencing cost a whopping $2.7 billion. That didn’t bode well for making any breakthroughs on genetic disorders. Luckily, the cost has dropped dramatically since then, leading to a new breed of consumer genetics startups taking a deeper dive into all the double helix’s that make up you. Genos is one of those startups using a next-generation… Read More

  • 23andMe reportedly no longer working on next-gen sequencing

    23andMe reportedly no longer working on next-gen sequencing

    23andMe won’t continue with next-generation DNA sequencing and has reportedly laid off the lab working on the project. About half-a-dozen workers were laid off from the Salt Lake City, Utah-based lab, according to BuzzFeed, which first reported the news. By our own count based on LinkedIn, at least five members of the lab have been let go, including its chief medical officer, Dr. Read More

  • What happens if we live to be 150? Crunch Network

    What happens if we live to be 150?

    Humans have lived for approximately 8,000 generations, but only in the past four has life expectancy taken dramatic leaps upward thanks mostly to societies addressing some of the most basic life issues. In 1907, the average human life expectancy was 46 years; in 1957, it rose to 66; in 2007, it reached 76. But I predict we won’t stop there. Read More

  • Bio
    Rex Animal Health is using genomics to keep livestock healthy

    Rex Animal Health is using genomics to keep livestock healthy

    A startup called Rex Animal Health wants to protect livestock from illnesses that can quickly turn into epidemics, and help farmers breed animals with the healthiest and most attractive traits. Today at Disrupt SF, Rex unveiled technology to help veterinarians provide clinical support at the point on the farm, and predict the genetic causes of problematic traits in their herds, and in the… Read More

  • Is enterprise genomics good enough yet? Crunch Network

    Is enterprise genomics good enough yet?

    Genomics will make the dream of targeted therapies a reality, which will have a massive health and economic impact. Yet most large life science enterprises, from pharma to providers, have yet to fully adopt genomics as part of their toolkit for clinical trials, development, commercialization and diagnostics. Read More

  • Innovation in genomics and the future of medtech  Crunch Network

    Innovation in genomics and the future of medtech 

    The field of medicine is in the process of being profoundly transformed by new technologies; much of this transformation comes from exciting advances in genomics. Although genomics is relatively unknown to the general public, innovations in the field have started to make headlines: Genetic testing startup 23andMe, the “gene editing” technology CRISPR and the ambitious 100,000… Read More